![Carl Tobias Sjöblom](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Carl Tobias Sjöblom
Oprichter bij ExScale Biospecimen Solutions AB
Profiel
Carl Tobias Sjöblom is the founder of ExScale Biospecimen Solutions AB, a company founded in 2012, where he holds the title of Director.
He is currently working as a Director at Oncodia AB.
Actieve functies van Carl Tobias Sjöblom
Bedrijven | Functie | Begin |
---|---|---|
ExScale Biospecimen Solutions AB
![]() ExScale Biospecimen Solutions AB BiotechnologyHealth Technology ExScale Biospecimen Solutions AB provides automated, next generation technology for nucleic acid extraction from formalin-fixed, paraffin-embedded tissue sections using paramagnetic beads. It specializes in processes and know-how for nucleic acid extraction from human tissue specimens. The firm's technology enables serial extraction of DNA and RNA from the same bio-specimen where the isolated nucleic acids are of optimal quality for next generation sequencing and other downstream applications. It offers ExScale NGEx kit which consists of plastic-ware, reagents packed into prefilled cartridges and a deparaffinisation reagent. The company was founded by Lucy Mathot and Carl Tobias Sjöblom in 2012 and is headquartered in Uppsala, Sweden. | Oprichter | 01-01-2012 |
Oncodia AB
![]() Oncodia AB Packaged SoftwareTechnology Services Oncodia AB develops regulatory compliant software for mutation analysis in clinical diagnostics. The company is based in Uppsala, Sweden. The Swedish company was founded by Ivaylo Stoimenov. The CEO is Kristofer Maad. | Directeur/Bestuurslid | 01-01-2018 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
ExScale Biospecimen Solutions AB
![]() ExScale Biospecimen Solutions AB BiotechnologyHealth Technology ExScale Biospecimen Solutions AB provides automated, next generation technology for nucleic acid extraction from formalin-fixed, paraffin-embedded tissue sections using paramagnetic beads. It specializes in processes and know-how for nucleic acid extraction from human tissue specimens. The firm's technology enables serial extraction of DNA and RNA from the same bio-specimen where the isolated nucleic acids are of optimal quality for next generation sequencing and other downstream applications. It offers ExScale NGEx kit which consists of plastic-ware, reagents packed into prefilled cartridges and a deparaffinisation reagent. The company was founded by Lucy Mathot and Carl Tobias Sjöblom in 2012 and is headquartered in Uppsala, Sweden. | Health Technology |
Oncodia AB
![]() Oncodia AB Packaged SoftwareTechnology Services Oncodia AB develops regulatory compliant software for mutation analysis in clinical diagnostics. The company is based in Uppsala, Sweden. The Swedish company was founded by Ivaylo Stoimenov. The CEO is Kristofer Maad. | Technology Services |